Gesco AG

  • WKN: A1K020
  • ISIN: DE000A1K0201
  • Land: Deutschland

Nachricht vom 13.10.2021 | 12:00

GESCO AG plans merger into European company (SE) with dual management system

Gesco AG / Key word(s): Miscellaneous
GESCO AG plans merger into European company (SE) with dual management system

13-Oct-2021 / 12:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

GESCO AG plans merger into European company (SE) with dual management system

Wuppertal, 13 October 2021 - The Executive Board and Supervisory Board of GESCO AG today resolved to transfer GESCO AG into a European company (Societas Europaea or SE), trading as GESCO SE, by way of a merger by acquisition according to Article 2 (1) of Council Regulation (EC) No. 2157/2001 of 8 October 2001 on the Statute for a European company (SE).

The current dual management system of GESCO AG, consisting of the Executive Board with responsibility for business affairs and the Supervisory Board as a monitoring authority, will remain in place in the new SE legal structure. GESCO SE is to be registered in Wuppertal, Germany. The transformation is to be achieved by merging wkk 1. Beteiligung AG, registered in Vienna into GESCO AG and changing the legal form into an SE.

The transformation requires that the GESCO AG Annual General Meeting agrees to the merger plan. If possible, the regular Annual General Meeting planned for 2022 should address the proposal for resolution.

The legal status of GESCO AG shareholders remains fundamentally unaffected by the merger of GESCO AG into an SE. Shareholders will continue to hold the same number of no-par-value registered shares. There will also be no increase in the total number of shares in GESCO AG, as the merger is to take place without any new shares being issued. Stock market trading will also be unaffected by the SE transformation.

Julia Pschribülla
Head of Investor Relations & Communications
Tel. +49 (0) 202 24820-18
Fax +49 (0) 202 24820-49
E-Mail: * *

13-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021